Amphastar Pharmaceuticals (AMPH) FCF Margin (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly FCF Margin of 25.51% for Q1 2026, up 917.0% year-over-year from 2.51% in Q1 2025, and up 89.95% quarter-over-quarter from 13.43% in Q4 2025.
Amphastar Pharmaceuticals (AMPH) FCF Margin (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' FCF Margin history runs 14 years deep, the most recent figure standing at 25.51% for Q1 2026.
- In Q1 2026, FCF Margin rose 917.0% year-over-year to 25.51%; the TTM figure through Mar 2026 stood at 19.02% (down 202.0% YoY), while the FY2025 annual figure was 16.84%, down 670.0% from the prior year.
- FCF Margin for Q1 2026 stood at 25.51%, up from 13.43% in the prior quarter.
- The five-year high for FCF Margin was 39.02% in Q2 2024, with the low at 3.7% in Q4 2024.
- The 5-year median for FCF Margin is 24.18% (2022), against an average of 21.58%.
- Peak annual rise in FCF Margin reached 3396 bps in 2022, while the deepest fall reached 3294 bps in 2022.
- Amphastar Pharmaceuticals' FCF Margin stood at 9.92% in 2022, then soared by 172 bps to 27.03% in 2023, then sank by 114 bps to 3.7% in 2024, then soared by 463 bps to 13.43% in 2025, then jumped by 90 bps to 25.51% in 2026.
- Business Quant data shows AMPH's FCF Margin at 25.51% in Q1 2026, 13.43% in Q4 2025, and 16.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 933.76 Mn | 643.64 Mn | 93.47 Mn | 23.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.24% |
| Mar 31, 2026 | 25.51% |
| Dec 31, 2025 | 13.43% |
| Sep 30, 2025 | 16.69% |
| Jun 30, 2025 | 21.07% |
| Mar 31, 2025 | 16.34% |
| Dec 31, 2024 | -3.70% |
| Sep 30, 2024 | 32.20% |
| Jun 30, 2024 | 39.02% |
| Mar 31, 2024 | 27.06% |
| Dec 31, 2023 | 27.03% |
| Sep 30, 2023 | 29.99% |
| Jun 30, 2023 | 31.48% |
| Mar 31, 2023 | 22.07% |
| Dec 31, 2022 | 9.92% |
| Sep 30, 2022 | 24.18% |
| Jun 30, 2022 | -2.09% |
| Mar 31, 2022 | 36.60% |
| Dec 31, 2021 | 27.76% |
| Sep 30, 2021 | -9.78% |